Mobile technology company Qstream announced on Friday that it has received a cash prize of EUR30,000 in recognition of its proven capabilities to help people with type 2 diabetes better manage glucose levels following the runner up position in the Ascensia Diabetes Challenge.

The Ascensia Diabetes Challenge is a global innovation competition focused on finding innovative digital solutions to support type 2 diabetes management.

Developed at Harvard Medical School by Qstream founder, Dr B. Price Kerfoot, Qstream is clinically proven in more than 20 scientific trials to boost retention and durably change clinical practice patterns to improve patient outcomes.

A recent clinical study found type 2 diabetes patients who were randomly assigned to use Qstream had significantly greater reductions in hemoglobin A1c (HbA1c), a common measure of long-term blood glucose control, than their counterparts who received the identical content in a booklet format.